“Safe and Effective Delivery of Aerosolized Medications in the Era of COVID-19”
Event Navigation
Saxe Communications & Philips Healthcare* present a program in the Better Outcomes webinar series…“Safe and Effective Delivery of Aerosolized Medications in the Era of COVID-19″
During the COVID-19 pandemic there has been concern regarding staff exposure from delivering aerosolized medications to patients with the disease. This webinar will provide practical strategies on how to deliver aerosolized medications to patients with COVID-19 safely and effectively. Infection control and prevention in the era of COVID-19 will also be discussed.
Learning Objectives | At the completion of this activity, the participant will be able to:
- Describe how aerosols and droplets may be the source of respiratory pathogens.
- Describe practical strategies on how to deliver aerosolized medications to patients with COVID-19 safely and effectively.
- Discuss infection control and prevention to mitigate provider risk associated with aerosolized medications for patients with COVID-19.
Presenter: ARZU ARI, PhD, RRT, PT, CPFT, FAARC, FCCP | Professor & Researcher | Texas State University
Target Audience: Nurses & Respiratory Therapists.
Continuing Education for Nurses and Respiratory Therapists. Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.
Support for this educational activity from Philips.
Questions should be addressed by Philips via Emily Eberly: 513-579-0800 | Producer@WebinarCreativeTechnology.com
* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
